| Epigenetic Variation at 8q24 and Prostate Cancer Risk |
Kathryn Barry |
University of Maryland School of Medicine |
PLCO |
Oct 22, 2012 |
2012-0282 |
| Epigenomic and functional effects of PFOA/PFOS exposures on ovarian cancer (OC) risk loci |
Marcin Iwanicki |
Stevens Institute of Technology |
PLCO |
Sep 7, 2023 |
PLCO-1301 |
| Epigenotyping in Peripheral Blood Cell DNA and Risk of Breast Cancer |
Susan Sturgeon |
UMASS Amherst |
PLCO |
Mar 3, 2010 |
2009-0553 |
| Errors and uncertainty in the estimation of dietary mis-reporting in studies using doubly-labelled water to estimate energy intake |
Mark Hopkins |
University of Leeds |
IDATA |
Aug 10, 2020 |
IDATA-38 |
| Establishing a Physical Activity Regularity Index |
Seth Creasy |
University of Colorado Denver |
IDATA |
Jan 11, 2019 |
IDATA-29 |
| Establishing Equivalence of Commonly Used Physical Activity Measures Using Testing Equating |
Zezhao Chen |
University of Illinois at Urbana Champaign |
IDATA |
Nov 13, 2018 |
IDATA-28 |
| Establishing risk factors for bladder cancer to inform prevention: a pooled analysis of prospective studies from the NCI Cohort Consortium |
Roger Milne |
Cancer Council Victoria |
PLCO |
Jul 15, 2021 |
PLCO-810 |
| Establishment of CTDI library for a CT organ dose calculation tool, NCICT |
Choonsik Lee |
National Cancer Institute, National institutes of Health |
NLST |
Aug 9, 2012 |
201209-0031 |
| Establishment of Screening Center Satellites |
Bonita Wohlers |
University of Utah/Boise |
NLST |
Jul 23, 2008 |
2008-00042 |
| Estimated Radiation Dose to Participants Receiving Chest X-Rays in the National Lung Screening Trial (NLST) |
Michael Flynn |
Henry Ford Health System |
NLST |
Sep 28, 2009 |
200909-0088 |
| Estimate heritability of survival for selected diseases |
Jianxin Shi |
National Cancer Institute |
PLCO |
Aug 20, 2020 |
PLCO-661 |
| Estimating and generalizing the complier average treatment effect in the PLCO trial |
Bo Zhang |
Fred Hutchinson Cancer Center |
PLCO |
Sep 28, 2023 |
PLCO-1336 |
| Estimating bladder cancer risk with novel AI models |
Nicolas Martelin |
Prostperia SAS |
PLCO |
Nov 13, 2023 |
PLCO-1382 |
| Estimating heterogeneous survival treatment effects of colorectal cancer screening approaches: A causal machine learning analysis |
Wang Zhe |
Weifang Medical University |
PLCO |
Sep 14, 2021 |
PLCO-824 |
| Estimating heterogeneous treatment effect of lung cancer in PLCO trial |
Yang Zhao |
Nanjing Medical University |
PLCO |
Nov 13, 2018 |
PLCO-424 |
| Estimating Lead Time, Sojourn Time and Sensitivity Through Modeling |
Paul Pinsky |
NCI, DCP, EDRG |
PLCO |
Jul 1, 2006 |
2006-0014 |
| Estimating Overdiagnosis in Cancer Screening Studies |
Ruth Etzioni |
Fred Hutchinson Cancer Research Center |
PLCO |
Apr 11, 2016 |
PLCO-205 |
| Estimating Patient-Specific Benefits and Harms of Low-Dose Computed Tomography Screening For Lung Cancer |
Kyle Schmaus |
Archimedes, Inc. |
NLST |
Jul 23, 2013 |
NLST-26 |
| Estimating Patient-Specific Benefits and Harms of Low-Dose Computed Tomography Screening For Lung Cancer |
Kyle Schmaus |
Archimedes, Inc. |
PLCO |
Jul 29, 2013 |
PLCO-43 |
| Estimating the cost effectiveness of lung screening in the Australian setting |
Marianne Weber |
Cancer Council NSW |
NLST |
Sep 15, 2015 |
NLST-161 |
